bioRxiv Science⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/051045

How strongly does appetite counter weight loss? Quantification of the homeostatic control of human energy intake

David Polidori·Arjun Sanghvi·Randy Seeley·Kevin D Hall
View original source ↗Export metadata ↓

Abstract

ObjectiveTo quantify the homeostatic feedback control of energy intake in response to long-term covert manipulation of energy balance in free-living humans.\n\nMethodsWe used a validated mathematical method to calculate energy intake changes during a 52 week placebo-controlled trial in 153 patients treated with canagliflozin, a sodium glucose co-transporter inhibitor that increases urinary glucose excretion thereby resulting in weight loss without patients being directly aware of the energy deficit. We analyzed the relationship between the body weight time course and the calculated energy intake changes using principles from engineering control theory.\n\nResultsWe discovered that weight loss leads to a proportional homeostatic drive to increase energy intake above baseline by ~100 kcal/day per kg of lost weight - an amount more than 3-fold larger than the corresponding energy expenditure adaptations.\n\nConclusionsWhile energy expenditure adaptations are often thought to be the main reason for slowing of weight loss and subsequent regain, feedback control of energy intake plays an even larger role and helps explain why long-term maintenance of a reduced body weight is so difficult.\n\nFundingThis research was supported by the Intramural Research Program of the NIH, National Institute of Diabetes & Digestive & Kidney Diseases, using data from a study sponsored by Janssen Research & Development, LLC.\n\nDisclosureD.P. is a full-time employee of Janssen Research & Development, LLC. K.D.H. reports patent pending on a method of personalized dynamic feedback control of body weight (US Patent Application No. 13/754,058; assigned to the NIH) and has received funding from the Nutrition Science Initiative to investigate the effects of ketogenic diets on human energy expenditure. R.S. is a paid consultant for Janssen, Novo Nordisk, Takeda, Daichii Sankyo, Novartis, Pfizer, Nestle, Circuit Therapeutics and Ethicon. R.S., also has received research support from Novo Nordisk, Ethicon, Sanofiand Boehringer Ingelheim. A.S. reports no conflicts of interest.\n\nWhat is already known about this subject?O_LIHuman body weight is believed to be regulated by homeostatic feedback control of both energy intake and energy expenditure.\nC_LIO_LIAdaptations of energy expenditure to weight loss have been well-established, but the homeostatic control of energy intake has yet to be quantified.\nC_LI\n\nWhat this study addsO_LIWe provide the first quantification of the homeostatic control of energy intake in free-living humans.\nC_LIO_LIThe increase in energy intake per kg of weight lost is several-fold larger than the known energy expenditure adaptations.\nC_LIO_LIHomeostatic control of energy intake is likely the primary reason why it is difficult to achieve and sustain large weight losses.\nC_LI

Source connections

Explore related subjects

PhysiologyPreprint

Keep this discovery

BibTeXRIS

David Polidori, Arjun Sanghvi, Randy Seeley, Kevin D Hall. 2016-04-29. How strongly does appetite counter weight loss? Quantification of the homeostatic control of human energy intake. https://doi.org/10.1101/051045

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2016

Lactobacillus plantarum favors the early emergence of fit and fertile adult Drosophila upon chronic undernutrition

Animals are naturally surrounded by a variety of microorganisms with which they constantly interact. Among these microbes, some live closely associated with a host and form its microbiota. These communities are now extensively studied, owing to their contributions to shaping various aspects of animal physiology. One of these commensal species, Lactobacillus plantarum, and in particular the L.p.WJL strain, has been shown to promote the growth of Drosophila larvae upon nutrient scarcity, allowing earlier metamorphosis and adult emergence compared to axenic individuals. As for many insects, conditions surrounding the post-embryonic development dictate key Drosophila adult life history traits, and adjusting developmental timing according to the environment is essential for adult fitness. The growth acceleration induced by L.p.WJL occurs in a context of poor nutrition and we wondered if this could adversely impact the fitness of Drosophila adults. Here we show that the L.p.WJL- mediated acceleration of growth is not deleterious; adults emerging after an accelerated development are as fit as their axenic siblings. Additionally, L.p.WJLs presence even leads to a lifespan extension in nutritionally challenged males. These results demonstrate that L.p.WJL is a beneficial partner for Drosophila melanogaster through its entire life cycle. This commensal bacteria allows the earlier emergence and longer survival of fit and fertile individuals and might represent one of the factors contributing to the ecological success of Drosophila.\n\nSummary statementLactobacillus plantarumWJL is beneficial to Drosophila physiology along its entire life cycle. This bacteria triggers the early emergence and longer survival of fit and fertile adults.

Physiology↗
bioRxiv2016

Disruption of Hepatocyte Jak2 leads to Spontaneous NASH in Aged Mice and Uncouples Metabolic Liver Disease from Insulin Resistance

Growth Hormone (GH) is a master regulator of metabolic homeostasis and longevity. Whole body GH insensitivity (GHI) augments insulin sensitivity, age-related disease resistance, adiposity, and occurrence of NAFLD. Conversely, acromegalic patients are prone to diabetes and increased mortality due to constitutive high levels of circulating GH. However, which tissues control the various metabolic aspects of GH physiology are unknown. Therefore, we determined the role of GH in age-related metabolic dysfunction by inducing hepatocyte- (JAK2L) or adipocyte-specific (JAK2A) GHI individually or combinatorially (JAK2LA) via deletion of Jak2, an obligate transducer of GH signaling. Aged JAK2L mice were insulin resistant but lean and had significant NASH, hepatic inflammation, and fibrosis. In contrast, JAK2A animals had increased adiposity and were completely resistant to age-associated hepatic steatosis, NASH, and insulin resistance. Interestingly, while JAK2LA mice retained enhanced whole-body insulin sensitivity, they still developed NASH to an almost identical degree as JAK2L mice but with a substantial reduction in the degree of microvesicular steatosis. Collectively, loss of adipocyte Jak2 conferred whole body insulin sensitivity even in the face of obesity and NASH. Deletion of hepatocyte Jak2 promoted NASH in aged mice without any dietary or drugs perturbations. The effect appears to be liver autonomous and cannot be overcome by the insulin sensitizing effect of adipocyte Jak2 deletion. Here, we describe the first model of spontaneous NASH that is coupled to augmented insulin sensitivity. Further, there was an inverse correlation between insulin sensitivity and the degree of microvesicular steatosis. Therefore, GH signaling independently mediates insulin/glucose and lipid homeostasis and directly regulates the development of NASH in aged mice.\n\nFinancial SupportThis study was supported by National Institutes of Health (NIH) Grants 1R01DK091276 (to E.J.W.). We also acknowledge the support of the University of California, San Francisco (UCSF) Cardiovascular Research Institute, the UCSF Diabetes Center (P30 DK063720), the UCSF Liver Center (P30 DK026743, and the James Peter Read Foundation.\n\nAbbreviations

Physiology↗
bioRxiv2016

Adipocyte JAK2 mediates hepatic insulin sensitivity and the diabetogenic action of Growth Hormone

For nearly 100 years, Growth Hormone (GH) has been known to impact insulin sensitivity and risk of diabetes. However, the tissue governing the effects of GH signaling on insulin and glucose homeostasis remains unknown. Excess GH reduces fat mass and insulin sensitivity. Conversely, GH insensitivity (GHI) is associated with increased adiposity, augmented insulin sensitivity, and protection from diabetes. Here we induce adipocyte-specific GHI through conditional deletion of Jak2 (JAK2A), an obligate transducer of GH signaling. Similar to whole-body GHI, JAK2A mice had increased adiposity and extreme insulin sensitivity. Loss of adipocyte Jak2 augmented hepatic insulin sensitivity and conferred resistance to diet-induced metabolic stress without overt changes in circulating fatty acids. While GH injections induced hepatic insulin resistance in control mice, the diabetogenic action was absent in JAK2A mice. Adipocyte GH signaling directly impinged on both adipose and hepatic insulin signal transduction. Collectively, our results show that adipose tissue governs the effects of GH on insulin and glucose homeostasis. Further, we show that JAK2 mediates liver insulin sensitivity via an extra-hepatic, adipose tissue-dependent mechanism.

Physiology↗